Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204971 · ClinicalTrials.gov registry record · Phase 4
Enteral Glutamine in Neurologically-injured Patients
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
NCT00204971 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 102 participants.
The verdict
NCT00204971, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
Study Summary
Nutrition is an important part of the recovery process after having a head injury so that subjects can gain strength and fight off infection. Liquid nutrition formulas are often given to patients through a tube that has been placed into the intestines for feeding when they are unable to eat on their own. Some reports suggest that nutrition with extra amounts of the amino acid called glutamine may decrease infections and hospital stay in severely injured patients.The purpose of this study is to evaluate if giving extra amounts of an amino acid called glutamine with liquid nutrition formulas will decrease the risk of infection and length of stay in the intensive care unit after having a head injury.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT Enteral glutamine powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00204971
The ClinicalTrials.gov registry entry for NCT00204971 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00204971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00204971 about?
NCT00204971 is a clinical study titled "Enteral Glutamine in Neurologically-injured Patients". Nutrition is an important part of the recovery process after having a head injury so that subjects can gain strength and fight off infection. Liquid nutrition formulas are often given to patients through a tube that has been placed into the intestines for feeding when they are unable to eat on their...
What is the current status of trial NCT00204971?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2003-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00204971?
The interventions under investigation include: placebo (OTHER), Enteral glutamine powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00204971?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.